Honokiol (HNK), an important medicinal component of Magnolia officinalis, is reported to possess pharmacological activities against a variety of diseases. However, the molecular mechanisms of HNK medicinal functions are not fully clear. To systematically study the mechanisms of HNK action, we screened a yeast mutant library based on the conserved nature of its genes among eukaryotes.
The baker's yeast Saccharomyces cerevisiae is a common eukaryotic model that has been widely used for medical and medicinal research. 10 It is used as a model because a considerable number of genes involved in human diseases have yeast functional homologs. 11 Furthermore, hundreds of yeast genes corresponding to key components in signal transduction or specific metabolic processes are linked to human disease-related molecular events. Meanwhile, advances in yeast technology have generated genome-wide screening approaches for both fundamental and applied research. 12 The screening of yeast mutant libraries has been used to determine the molecular mechanisms of drugs by detecting resistance and sensitivity of yeast. 12, 13 In this study, strains in a yeast mutant library were treated for 24 hours with half the concentration of HNK that was lethal for the wild-type strain. Resistant and sensitive mutants were identified using growth assays. We found that 44% of mutants classified as resistant were petite with mutations in mitochondrial genes. These petite were also partly off-target from HNK to become HNK resistant.
| RESULTS

| HNK-resistant petite mutants identified through high-throughput yeast mutant library screening
To examine genes involved in mediating resistance and sensitivity to HNK, we systematically screened a yeast mutant library from S. cerevisiae BY4741 with two collections: YSC5095 (Yeast DAmP Library) for 842 essential genes; and YSC1053 (Yeast Deletion Library)
for 5153 nonessential genes, in YPD liquid medium with 12 μg/mL HNK (IC 50 ). We identified 276 strains resistant to HNK and 175 sensitive to HNK in comparison with wild-type (Table S2 , Supporting Information). We classified the genes by Gene Ontology (GO) enrichment according to biological processes using the Molecule Annotation System (MAS3.0, http://bioinfo.capitalbio.com/mas3/). Processes that were significantly enriched (P-value <0.05) were selected as functional categories, and overlapping processes manually merged (Tables S3   and S4 and Figure 1 ). Mutated genes associated with mitochondria and respiration constituted the largest group of resistant mutants,
accounting for 43 open reading frames (ORFs; 15.5%; Figure 1A ).
As a large number of resistant mutants were related to mitochondria, we determined if they had defects in mitochondrial function.
Yeast generates energy under aerobic and anaerobic conditions in YPD but only under aerobic conditions in YEPG. 14 The 138 strains classified as resistant were plated on YEPG on which only cells acquiring energy from mitochondria could grow. Cells with respiratory deficiencies in mitochondria did not grow on YEPG with glycerol as the carbon source. Among the 138 resistant strains, a large fraction (61 ORFs, 44%) of the resistant strains was confirmed to be linked to mitochondrial dysfunction because they formed petites on YEPG, consistent with their descriptions in the Saccharomyces Genome Database (SGD, http://www.yeastgenome.org/; Table S3 ). Therefore, dysfunctional mitochondria petite mutants were HNK resistant.
| Mechanisms of HNK resistance in petite mutants
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Vitamin metabolism (4) V a c u o la r H ( + ) A T P a s e ( 8 ) Lipid metabolism (4) C e ll w a ll a n d m e m b ra n e (6 ) Cell cycle (12) Small GTPase (4) D N A d a m a g e r e p a ir ( 8 ) Nucleotide metabolism (4) Figure 2F ). Overexpression of ATP7 suppressed the respiratory deficiency and HNK resistance in atp7Δ mutant cells, but did not suppress HNK resistance in wild-type cells ( Figure S1A ).
Meanwhile, some other HNK-resistant mutants were also confirmed to be petites ( Figure S1D ). These results indicated that the intrinsic resistance to HNK of petite mutants may result from mitochondrial defects.
Previous studies demonstrated that resistance to azoles in Candida glabrata petite mutants is due to increased expression of the transcriptional activator CgPDR1 and its target genes. 15 The homologous genes in S. cerevisiae are PDR3 and PDR5. From the "Response to drug" functional category (Table S4) , we found that pdr5Δ cells were sensitive to HNK. We hypothesized that PDR5, encoding an ABC transporter, was induced in yeast petite mutants. To examine the expression of the Pdr5 protein in atp7Δ and atp15Δ mutants, we tagged the C-terminus of Pdr5 with green fluorescent protein (GFP)
for fluorescence observation and immunoblotting assays. Like nonPdr5-GFP-tagged atp7Δ and atp15Δ cells ( Figure 2F ), Pdr5-GFPtagged atp7Δ and atp15Δ cells were still HNK-resistant and petites ( Figure 2A) . Furthermore, the Pdr5-GFP signal was stronger in atp7Δ
and atp15Δ mutants than in wild-type cells under the same conditions ( Figure 2B ). Immunoblots confirmed a significant increase in the Pdr5-GFP-tagged yeast cells were grown to log phase at 26 C and Pdr5-GFP fluorescence was observed by microscopy. Scale bar, 5 μm. (C) The
Pdr5-GFP protein is increased in atp7Δ and atp15Δ mutants. Cells were grown as in (B) and Pdr5-GFP protein was determined in cell lysates using western blots with anti-GFP (G6PDH served as a loading control Figure S1B) and atp7Δ mutant cells retained less rhodamine 6G ( Figure S1C ). Similar results were obtained with other petite mutants that showed either more rhodamine 6G uptake or less rhodamine 6G retention except for coq9Δ, which had less rhodamine 6G uptake and retention ( Figures S1E and F) . Taken together, these results suggested that increased Pdr5 in petite mutants resulted in pumping out more rhodamine 6G. We asked if more HNK was pumped out of yeast petite mutants. We employed a method similar to detecting the efflux ratio of rhodamine 6G to examine the efflux ratio of HNK in wild-type and petite mutants by high-performance liquid chromatography (HPLC).
The HNK efflux ratio in atp7Δ and atp15Δ was higher than that in wild-type cells ( Figure 2D ). To more accurately reflect HNK transport across the plasma membrane mediated by Pdr5, we directly determined HNK retention in YPD medium in which uptake and efflux of HNK happened simultaneously. HNK retention in petite mutants was one-third of the retention in wild-type cells ( Figure 2E ). These results indicate that yeast petites pumped out more HNK due to increased Pdr5 expression.
To determine whether overexpression of Pdr5 in atp7Δ and atp15Δ is the only reason for the observed HNK resistance, we deleted PDR5 to see whether pdr5Δatp7Δ and pdr5Δatp15Δ remained resistant to HNK as suggested by an anonymous reviewer. The results showed that these double mutants were indeed still resistant to HNK ( Figure 2F ). Furthermore, pdr5Δatp7Δ and pdr5Δatp15Δ double mutants were less resistant to HNK than atp7Δ and atp15Δ single mutants ( Figure 2F ). These results suggest that Pdr5 contributes (but not alone) to HNK resistance. Petite mutants may also be partly offtarget from HNK to become HNK resistant.
| HNK treatment targets mitochondria and results in mitochondrial dysfunction
Several HNK resistant "petite" mutants possess mutations in subunits of the ATP synthase such as Atp15 and Atp7 in mitochondria. As the pdr5Δatp7Δ and pdr5Δatp15Δ double mutants were still resistant to HNK ( Figure 2F ), HNK might directly target the ATP synthase, or alternatively, HNK toxicity might (indirectly) require ATP synthesis via oxidative phosphorylation.
In addition to HNK-resistant petite mutants, we also found several mitochondrial-related mutants that were sensitive to HNK ( Figure 1B ). Therefore, we tested if HNK treatment interfered with mitochondrial function. First we confirmed the sensitivity of mitochondrial mutants to HNK using YPD medium containing HNK ( Figure 3A) . Interestingly, these mitochondria mutants were not petite because they grew on YEPG as wild-type ( Figure 3A) . HNK. We found that the absolute ATP content was decreased in isolated mitochondria pellets following the 12 μg/mL HNK treatment, when the absolute ATP content was not significantly changed in total and in supernatants following the 12 μg/mL HNK treatment ( Figure 3D ). Furthermore, we found that the relative ATP content was decreased in isolated mitochondria pellets and slightly increased in supernatants following the 12 μg/mL HNK treatment, when the relative ATP content was not significantly changed in total following the 12 μg/mL HNK treatment ( Figure 3D ). These results suggest that HNK may destroy the mitochondrial integrity and reduce ATP production.
Among the mutated genes in mitochondria-related sensitive mutants, MIM1, MIA40 and MAS1 encoded proteins that are required for mitochondrial membrane protein import. [17] [18] [19] This finding indicated that incomplete mitochondria may be more susceptible to HNK.
To further confirm that HNK targeted mitochondria in wild-type cells,
we investigated the effect of HNK on morphological changes in mitochondrial membrane organization by tagging tdTomato at the Cterminus of the mitochondrial membrane protein Tom20 and DAPI staining of mitochondrial DNA together with tagging GFP at the Cterminus of the nuclear protein Htb1. In wild-type cells without HNK, mitochondria showed typical tubular network morphology by tdTomato-Tom20 localization ( Figure 3E ). Exposure to HNK resulted in fragmented and aggregated mitochondria. Htb1 is a nuclear histone protein. 20 Mitochondrial DNA was distinguished by differences between DAPI staining and Htb1-GFP fluorescence. Nuclear DNA was recognized because it showed both DAPI staining and Htb1-GFP fluorescence. Mitochondrial DNA was recognized because it showed only DAPI staining and no Htb1-GFP fluorescence. Exposure to HNK also resulted in morphological changes in mitochondrial DNA, with colocalization of Tom20 and mitochondrial DNA decreasing from 54%
without HNK treatment to 20% with 12 μg/mL HNK treatment ( Figure 3E ). Taken together, these results suggested that HNK treatment targets mitochondria and most likely disrupts mitochondrial morphology and function.
| HNK treatment promotes supersized LD formation
In the HNK-treated cells ( Figure 3E ), we found large black elements on phase contrast (PhC) images appeared to be LDs, based on a previous description. 21 HNK treatment seemed to increase the size of
LDs. An increasing body of evidence shows that LDs are involved in lipid metabolism and energy homeostasis through interactions with mitochondria. 22 Therefore, we hypothesized that mitochondria 
1/2 FIGURE 3 HNK seems to disrupt mitochondrial morphology and function. (A) Representative HNK-sensitive nonpetite mitochondria mutants. Wild-type (BY4741) and representative nonpetite mitochondria mutants were incubated on YEPG or YPD plates supplemented with 0 or 15 μg/ mL HNK. Cells were grown and photographed as in Figure 2A. (B) Wild-type (BY4741) cells were more sensitive to HNK on YEPG than YPD medium. BY4741 was grown on YPD plates for 3 days or YEPG plates for 5 days at 26 C with 0 or 15 μg/mL HNK. (C) ATP production was reduced in mitochondria from HNK-treated wild-type cells. Wild-type (BY4741) cells were treated with 0 or 12 μg/mL HNK and mitochondria were isolated. The ATP content was determined in supernatants and mitochondria pellets, and the total ATP was calculated from their summation. Data are presented as mean AE SD from two independent experiments. N.S., no significance. ***P < 0.001. (D) ATP production was reduced in HNK-treated isolated mitochondria from wild-type cells. Isolated mitochondria from wild-type (BY4741) cells were treated with 0 or 12 μg/mL HNK. Supernatants and mitochondrial pellets were used for measurement of ATP content. Data are presented as mean AE SD from three independent experiments. N.S., no significance. *P < 0.05. ***P < 0.001. Total ATP content was calculated from the summation of supernatant and mitochondrial pellet ATP content. (E) Observing the changes of mitochondria and mitochondrial DNA with HNK treatment. Mitochondrial membrane protein Tom20 was tagged with tdTomato at the C-terminus. Nuclear histone protein Htb1 was tagged with GFP at the C-terminus. Cells were grown to log-phase in YPD and supplemented with 0 or 12 μg/mL HNK for 2 hours. Nuclear and mitochondrial DNA were stained with DAPI (30 μg/mL) in the last hour of incubation before HNK treatment. Images were captured by microscope. Arrows, Tom20-tdTomato; arrowheads, mitochondrial DNA. Scale bar, 5 μm. Colocalization of Tom20 with mitochondrial DNA stained by DAPI was determined from two replicates and is presented as mean AE SD. **P < 0.01
found that the size of LDs in wild-type cells was increased, yielding "supersized" LDs 23 following HNK treatment ( Figure 4A,B) . LDs are reported to originate from the outer leaflet of the endoplasmic reticulum (ER). 24 Without HNK treatment, Erg6-mCherrymarked LDs were adjacent to Sec61-GFP-marked ER. With HNK treatment, Erg6-mCherry-marked round LDs enlarged and Sec61-GFP-marked ER changed from a tubular to a round shape.
Most To examine the origin and formation of supersized LDs caused by HNK treatment, we monitored the dynamics of Atp7-GFP-marked mitochondria and Erg6-mCherry-marked LDs using time-lapse live microscopy. We found that supersized LDs arose either from fusion of regular LDs, or growth of LDs surrounded by mitochondria, and possibly also ER, after HNK treatment ( Figure 5 and Movie S1). Figure S5A-C) . We therefore propose that, without a carbon source, neither wild-type nor atp7Δ mutant cells were able to pump HNK due to a lack of ATP for Pdr5 function.
To investigate whether the generation of enlarged LDs ultimately kills HNK-treated cells, we were suggested by an anonymous reviewer to test the effect of HNK on mutants that interfere with LD biogenesis. We found that several lipid metabolism-related mutants were either resistant or sensitive to HNK (Tables S3 and S4 , Figure S6A ). To investigate whether mutants with "supersized" LDs were more susceptible to HNK, we examined the LD morphology of representative mutants in YPD with different concentrations of HNK. As shown in Figure S6B ,C, we found that the size of LDs was increased in both 
| HNK promotes TAG synthesis
LD cores contain neutral lipids, predominantly sterol esters (SE) or
TAGs. 25 Synthesis of neutral lipids in yeast requires four enzymes:
Are1, Are2, Lro1 and Dga1. 26 The acyl-CoA: sterol acyltransferases Are1 and Are2 synthesize SE and both Lro1 and Dga1 produce TAG. 27 To examine which component of LDs increased following HNK treatment, we used mutants depleted for the four enzymes, that is, the wild-type strain with single, double and quadruple deletions.
Only mutants in which LRO1 was deleted showed less Nile Red fluorescence intensity than wild-type and the other mutants, although the diameter of LDs was increased in all strains after HNK exposure ( Figure 6A,B) . This result indicated that the Lro1-controlled lipid synthesis pathway was important for the formation of supersized LDs.
We hypothesized that HNK treatment induced TAG synthesis. Loss of the mitochondrial genome to form petite cells activates the pleiotropic drug resistance pathway via overexpression of PDR5, encoding an ATP-binding cassette transporter. 28 Upregulation of PDR5 in petite mutants depends on the presence of PDR3. 29 We reported that deleting PDR3 and PDR5 in a wild-type strain increases sensitivity to HNK. Pdr5 protein increases significantly in wild-type cells after HNK treatment. 30 These results indicate that Pdr5 is HNK inducible and involved in HNK resistance. Consistent with these findings, we found that Pdr5 expression was increased in atp7Δ and atp15Δ mutants that were petite and resistant to HNK (Figure 2A-C) .
The decreased HNK retention of these petite mutants supports the hypothesis that increased Pdr5 expression results in pumping out HNK for HNK resistance (Figure 2) . Furthermore, the Pdr5 pumping HNK function was energy-dependent. When ATP was produced in glucose-containing YPD medium in atp7Δ cells through fermentation, it drove Pdr5 function to remove HNK with no effect on mitochondria and LD morphology after HNK treatment. However, when no ATP was produced in glucose-minus SD-carbon medium in atp7Δ cells that could not perform fermentation, large, circular mitochondria and LD structures were formed after HNK treatment ( Figure S5A-C) . However, Pdr5 is not the only regulator of the toxic effects of HNK on yeast cells. When PDR5 was deleted in atp7Δ and atp15Δ mutants, the resultant pdr5Δatp7Δ and pdr5Δatp15Δ double mutant cells were still resistant to HNK relative to pdr5Δ, although more sensitive to HNK than atp7Δ and atp15Δ single mutant cells ( Figure 2F ), suggesting that Pdr5 contributes (but not alone) to HNK resistance, and the mitochondrial function itself is very important for HNK toxicity, maybe indirectly through oxidative phosphorylation. Taken together, these results implied that the acquired HNK resistance of petite mutants was at least a comprehensive consequence of activating the pleiotropic drug-resistance pathway and being partly off-target from HNK.
Among the categorized resistant mutants, some mitochondrialrelated mutants were not petites. These included mitochondrial morphology-related mutants she9Δ, psd1Δ and mdm30Δ; genome maintenance-related mutants pet20Δ and mrm2Δ; and mitochondrial protein transport-related mutants tim17-DAmP, tim23-DAmP and tam41-DAmP. Previous research shows that the psd1Δ and mdm30Δ
strains display fragmented and aggregated mitochondria. 31, 32 We found that HNK treatment also resulted in fragmented and aggregated mitochondria in wild-type cells ( Figure 3E ). Furthermore, HNK treatment alters mitochondrial morphology and distribution in C. albicans. 6 These results indicate that HNK treatment may target and disrupt mitochondrial function. Our measurements of ATP content in mitochondria isolated from HNK-treated wild-type cells or in HNK-treated isolated mitochondria from wild-type cells support the targeting of HNK against mitochondria ( Figure 3C,D) .
The role of mitochondria in regulating TAG metabolism has been thoroughly explored. Cellular TAG accumulation is regulated via mitochondrial fusion and fission processes. 33 Apoptosis-induced mitochondrial dysfunction diverts fatty acids into TAG synthesis and formation of LDs. 34 A study of mitochondrial defects shows that ZAP1 deletion slows ATP production, which may channel carbon flow toward lipid biosynthesis and storage as TAG. 35 In combination, these studies suggest that dysfunctional mitochondria with decreased ATP production may divert carbon flow to synthesize TAG for storage in 
| MATERIALS AND METHODS
| Strains, plasmids and reagents
Strains and plasmids used in this study are listed in Table S1 . ATP7
was cloned into the BamHI/XhoI sites of vector pRS425 (2μ, LEU2) and transformed into yeast as previously described. 42 
| Yeast mutant library screening
| Cell culture conditions and fluorescence microscopy
Saccharomyces cerevisiae cells were grown in YPD, SD-Leu (0.71% yeast nitrogen base without amino acids, 2% glucose, supplemented with all essential amino acids except leucine, 2% agar) or SG-Leu (2% glucose in SD-Leu was replaced with 3% glycerol) medium at 26 C.
Candida albicans was grown in YPD medium at 26 C. Schizosaccharomyces pombe was grown in yeast extract with supplements (YES) medium at 30 C. 44 Fusarium graminearum was grown in mung bean medium to produce spores at 26 C. 45 Human cells (HeLa and HL7702) were grown in Dulbecco's modified eagle medium (DMEM) supplemented with 10% (vol/vol) fetal bovine serum (FBS) at 37 C. 46 GFP and mCherry tagging were performed by homologous recombination using polymerase chain reaction (PCR) fusion cassettes. 47 TOM20-tdTomato-LEU2 was integrated into strains as previously described. 48 For LD staining, cells were incubated in phosphatebuffered saline (PBS) with 10 μg/mL Nile Red (Sigma-Aldrich) for 3 minutes at room temperature and washed twice with PBS. For DNA staining, 4 0 ,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) was added to log-phase cultures to a final concentration of 30 μg/mL in the last hour of incubation before HNK treatment. Fluorescence was examined with a Nikon Eclipse Ti inverted research microscope (Nikon Instech Co., Ltd., Tokyo, Japan) as previously described. 49 The diameter of LDs was calculated as the average diameter of the five biggest LDs in each cell. Statistical analysis was performed in Excel (Microsoft) using Student's t tests to compare pairs of strains.
Rhodamine 6G efflux was analyzed as previously described 50 filled with Syncronis C 18 (Thermo) and kept at 30 C. The mobile phase was methanol: water (98:2, vol/vol), and flow rate was 0.8 mL/min.
The detection wavelength was 293 nm, 54 and injection volume was 20 μL. All experiments were performed in triplicate. HNK standards (5-30 μg/mL) were used as a reference.
| Time-lapse imaging
Yeast cells were immobilized on glass bottoms of 20 mm cell culture dishes (NEST) coated with 1 mg/mL concanavalin A (Sigma-Aldrich). A 1 mL YPD medium containing 12 μg/mL HNK was used to cover cells before imaging. Atp7-GFP and Erg6-mCherry were detected using an UltraVIEW spinning-disk confocal scanner unit (PerkinElmer) with Volocity 6.3.0 software. Images were captured at a fixed rate of 10 seconds per time-point with three channels (Differential interference contrast, 488 nm and 561 nm) and three Z-slices (0.6-μm step size) for 1 hour at 26 C. The exposure time was 300 milliseconds, the sensitivity was 150 and the laser power was 15%.
| Western blotting
Expression of Pdr5-GFP was determined by western blotting as previously described. 55 Protein band intensities were analyzed by ImageJ software (National Institute of Health), and statistical data were calculated in Excel (Microsoft) using Student's t tests to compare pairs of strains.
| Transmission electron microscopy
Yeast cells were fixed with 2.5% glutaraldehyde, and postfixed with 2% (wt/vol) potassium permanganate solution, and stained with uranyl acetate and lead citrate as previously described. 56 Images were captured with a transmission electron microscope (Hitachi H7700).
